SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
To date, cancer diseases are one of the leading causes of mortality and morbidity in the world. Recent advances in understanding the molecular genetic mechanisms of oncogenesis and anti-cancer immune responses open new opportunities for the development of novel effective therapeutic strategies again...
Saved in:
| Main Authors: | T. S. Nepomnyashchikh, E. V. Gavrilova, R. A. Maksyutov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2019-05-01
|
| Series: | Медицинская иммунология |
| Subjects: | |
| Online Access: | https://www.mimmun.ru/mimmun/article/view/1580 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma
by: Joseph W. Jackson, et al.
Published: (2025-09-01) -
Therapy gone viral: Exploring the use of oncolytic viruses in non-small cell lung cancer immunotherapy
by: Jemima Steele, et al.
Published: (2025-01-01) -
Translation of oncolytic viruses in sarcoma
by: Steven I. Robinson, et al.
Published: (2024-09-01) -
Oncolytic Vesicular Stomatitis Virus: Optimisation Strategies for Anti-Cancer Therapies
by: Margarita Zinovieva, et al.
Published: (2024-10-01) -
Investigation of an oncolytic herpes simplex virus as a potential therapeutic agent for gastroenteropancreatic neuroendocrine neoplasms
by: Colin H. Quinn, et al.
Published: (2025-04-01)